Wave Life Sciences (WVE) Non Operating Income (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Non Operating Income data on file, last reported at $4.4 million in Q2 2026.

• Quarterly Non Operating Income rose 94.19% year-over-year to $4.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $15.4 million (up 13.27% YoY) and the FY2025 annual result came in at $11.0 million, down 17.84% from the prior year.
• Non Operating Income eased to $4.4 million in Q2 2026, from $5.2 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $6.3 million in Q4 2024 to a low of -$105000.0 in Q3 2022.
• A 5-year average of $2.5 million and a median of $2.4 million in 2023 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2022 — Non Operating Income sank 107.63% — and 2023, when it soared 2129.52%.
• Tracing WVE's Non Operating Income over 5 years: stood at $535000.0 in 2022, then soared by 353.46% to $2.4 million in 2023, then surged by 159.11% to $6.3 million in 2024, then plunged by 47.69% to $3.3 million in 2025, then soared by 35.25% to $4.4 million in 2026.
• The last three Non Operating Income figures came in at $4.4 million (Q2 2026), $5.2 million (Q1 2026), and $3.3 million (Q4 2025), per Business Quant data.